# The efficacy of non-complete omentectomy in the radical gastrectomy for gastric cancer: a meta-analysis and systematic review

## TL;DR

This study compares non-complete and complete omentectomy during gastric cancer surgery and finds similar outcomes, but suggests more research is needed.

## Contribution

A meta-analysis and systematic review comparing non-complete and complete omentectomy in gastric cancer surgery.

## Key findings

- NCO was associated with lower recurrence rates and fewer complications compared to CO.
- NCO showed higher 3- and 5-year survival rates but no significant difference in lymph node harvest or peritoneal recurrence.
- No significant advantage was found for NCO over CO in surgical, survival, or recurrence outcomes.

## Abstract

Surgery is considered a necessary treatment for gastric cancer (GC), but the extent of resection remains controversial. This study aimed to evaluate the efficacy of non-complete omentectomy (NCO) in GC patients undergoing radical gastrectomy.

We searched for studies of non-complete omentectomy versus complete omentectomy (CO) published before February 2024 from PubMed, Web of Science, and Cochrane Library databases. From the extracted clinical data, we compared surgical, survival, and recurrence outcomes between the two groups.

Thirteen studies with a total of 4255 patients were included. The meta-analysis showed that compared with the CO group, the NCO group was associated with a lower overall recurrence rate, shorter operative time, and fewer postoperative complications. However, there was no significant difference in the number of harvested lymph nodes and peritoneal recurrence rate between the two groups. The NCO group was associated with the higher 3-year overall survival (OS) rate (RR = 0.95, 95% CI = 0.91–0.99, P = 0.02), 5-year OS rate (RR = 0.91, 95% CI = 0.87–0.96, P = 0.0006), and 5-year relapse-free survival (RFS) rate (RR = 0.93, 95% CI = 0.87–0.99, P = 0.02). However, it was not associated with the 3-year RFS rate (RR = 0.95, 95% CI = 0.89–1.01, P = 0.12) compared with the CO group.

Regarding surgical, survival, and recurrence outcomes, performing NCO versus CO during radical gastrectomy provides no significant advantage. However, future high-quality and well-designed randomized controlled trials are necessary to validate the results.

The online version contains supplementary material available at 10.1007/s00423-025-03760-2.